Dave Pagliarini, PhD, whose studies of the so-called “powerhouses of the cell” have shed light on a set of rare but devastating diseases, has been named a BJC Investigator and will join the Department of Cell Biology & Physiology at Washington University School of Medicine in St. Louis. He will have secondary appointments in the biochemistry and genetics departments.
The BJC Investigators Program brings to the School of Medicine scientists whose innovative approaches to addressing important biological questions have the potential to lead to new ways of understanding disease and developing treatments.
Pagliarini currently is an associate professor of biochemistry at the University of Wisconsin-Madison and the lead investigator and Arthur C. Nielsen Jr. Chair of Metabolism at the Morgridge Institute for Research. His appointment begins May 1.